Abstract
Fluoxetine and L-deprenyl were prescribed concurrently in a 19-year-old female with Huntington's disease. The patient showed significant affective, behavioral, and motoric improvements and there was no adverse effect resulting from this combination. Concomitant use of L-deprenyl in low doses and fluoxetine may be safe and beneficial in certain clinical situations, although further study is needed.
Publication types
-
Case Reports
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adult
-
Anticonvulsants / therapeutic use
-
Antidepressive Agents, Second-Generation / therapeutic use*
-
Attention / drug effects
-
Carbamazepine / therapeutic use
-
Depression / complications
-
Depression / drug therapy*
-
Drug Interactions
-
Drug Therapy, Combination
-
Expressed Emotion / drug effects*
-
Female
-
Fluoxetine / therapeutic use*
-
Humans
-
Huntington Disease / complications
-
Huntington Disease / drug therapy*
-
Impulsive Behavior / complications
-
Impulsive Behavior / drug therapy
-
Monoamine Oxidase Inhibitors / pharmacology
-
Monoamine Oxidase Inhibitors / therapeutic use*
-
Movement / drug effects
-
Selegiline / therapeutic use*
-
Violence
Substances
-
Anticonvulsants
-
Antidepressive Agents, Second-Generation
-
Monoamine Oxidase Inhibitors
-
Fluoxetine
-
Selegiline
-
Carbamazepine